Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells

Panayotopoulou , Eg; Muller, Ak; Borries, M; Busch, H; HU, Gh; Lev, S (2017). Targeting of apoptotic pathways by SMAC or BH3 mimetics distinctly sensitizes paclitaxel-resistant triple negative breast cancer cells.  Oncotarget. 2017, 8 :45088-45104.